Skip to main content
Caplight Logo









FluidForm Bio

FluidForm Bio

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://www.fluidformbio.com/

Last Round

Seed Round

Aug 27, 2026

Total Funding Raised

$733,563

Momentum

Top 25%

of companies Caplight tracks

Company Overview

FluidForm Bio is a biotechnology company that develops life-extending tissue therapeutics and 3D bioprinting solutions using its patented FRESH™ technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, 3D Printing, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

3D bioprintingFRESH bioprintingtissue engineeringregenerative medicinebioprinting platformdrug discoveryFreeform Reversible Embedding of Suspended HydrogelsFRESHbioprinting hardwareorgan-on-a-chipbiological scaffoldcomputational biologybiotech R&Dlab-grown tissuebiomaterials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FluidForm Bio Comparables

Compare FluidForm Bio with similar companies based on industry and business-model similarity.

FluidForm Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Poietis
85%
Aspect Biosystems
82%
VascuBio Innovation
79%

FluidForm Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 27, 2026
Convertible DebtApr 16, 2025
StrategicJan 11, 2022
GrantMay 1, 2021
GrantApr 1, 2021

Key People

Founding team and executive leadership

Adam Feinberg

CTO and co-founder

Founding Team

Erik Waters

Chief Financial Officer

Executive Team

FluidForm Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2026

    Raised $2M in a seed funding round.

  • Jul 25, 2026

    Monthly visitors increased 58% MoM.

FluidForm Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FluidForm Bio Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range14
Year Founded2018
Last FundingAug 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?